help button home button Am J Pathol Epitomics Buy 2 Antibodies Get 1 Free Special Offer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nouwen, E. J.
Right arrow Articles by De Broe, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nouwen, E. J.
Right arrow Articles by De Broe, M. E.

American Journal of Pathology, Vol 126, 230-242, Copyright © 1987 by American Society for Investigative Pathology


REGULAR ARTICLES

Tumor markers in the human ovary and its neoplasms. A comparative immunohistochemical study

EJ Nouwen, PG Hendrix, S Dauwe, MW Eerdekens and ME De Broe

The incidence and histologic characteristics of the expression of placental alkaline phosphatase (PLAP) in ovarian tumors was compared with that of five other tumor antigens. Three monoclonal antibodies were used for the specific localization of PLAP. PLAP was present in some sex cord cells of the 13-16-week fetal ovary, probably germ cells. In normal ovaries, all antigens except carcinoembryonic antigen (CEA) were frequently found in inclusion cysts; the germinal epithelium was positive only for cancer antigen 125 (CA 125). The frequency and extent of PLAP expression in nonmucinous carcinomas was higher than observed for CA 19-9 and CEA, but was lower than for CA 125 and human milk fat globule antigen. Serous tumors had the highest PLAP expression, followed by endometrioid and poorly differentiated adenocarcinomas, and some other tumors. PLAP was predominantly membranous; its histologic distribution was in general heterogeneous. Different antibodies to PLAP gave different staining intensities in some tumors, but the staining patterns were always qualitatively identical.


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Lukanova and R. Kaaks
Endogenous Hormones and Ovarian Cancer: Epidemiology and Current Hypotheses
Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 98 - 107.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
N. Auersperg, A. S. T. Wong, K.-C. Choi, S. K. Kang, and P. C. K. Leung
Ovarian Surface Epithelium: Biology, Endocrinology, and Pathology
Endocr. Rev., April 1, 2001; 22(2): 255 - 288.
[Abstract] [Full Text]


Home page
Hum ReprodHome page
M. Epiney, C. Bertossa, A. Weil, A. Campana, and P. Bischof
CA125 production by the peritoneum: in-vitro and in-vivo studies
Hum. Reprod., June 1, 2000; 15(6): 1261 - 1265.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
D. A. Gould, G. J. Moscoso, M. P. A. Young, and D. P. J. Barton
Human First Trimester Fetal Ovaries Express Oncofetal Antigens and Steroid Receptors
Reproductive Sciences, March 1, 2000; 7(2): 131 - 138.
[Abstract] [PDF]


Home page
INT J SURG PATHOLHome page
M. J. Costa, M. B. Kenny, and R. Judd
Adenocarcinoma and Adenosquamous Carcinoma of the Uterine Cervix: Histologic and Immunohistochemical Features With Clinical Correlation
International Journal of Surgical Pathology, January 1, 1994; 1(3): 181 - 189.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1987 by the American Society for Investigative Pathology.